Pediatrix Medical Group Inc. Common Stock (MD) fair value

ACCE thesis

Pediatrix Medical Group (MD) runs neonatal intensive care, maternal-fetal medicine and pediatric anesthesia services, staffed by physician groups it contracts into hospitals, which makes it a physician-practice business more than a facility operator. Its moat is the scale and reputation of those contracted neonatal units, which are hard for hospitals to replace once a group is embedded, and the steady volume of high-acuity births keeps that demand recurring. The stock trades at 12.7 times trailing earnings and 9.3 times forward, a sizable discount to where the earnings base implies, with return on equity of 20.4% and an operating margin of 13.4%. Revenue growth of 4.0% is modest, so the case rests on margin discipline and cash conversion rather than top-line acceleration, and that is the point to test in the filings. Worth a deeper look to see whether the forward multiple compression reflects reimbursement or payer-mix risk that the headline numbers don't show.